THOUSAND OAKS, Calif., Sept. 20, 2023 – Amgen today announced the launch of Amgen Partners of Choice, a new network that brings together Amgen’s oncology research and development experts and world-class clinical leaders at eight research centers across the globe.…
FLORENCE (Italy) and NEW YORK, NY, September 20, 2023 – The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, announced today that the European Commission has…
👉 Given as few as six times per year, cabotegravir has demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition in clinical trials.1,2,3,4 👉 With approximately 100,000 people newly diagnosed with…
These critical initiatives come as the global healthcare company confirms its commitment to positively impact society by tackling climate change and its consequences for human health. Ramping up adaptation efforts and initiatives to address the impact of climate change on the health of…
Around 1 in every 10 patients is harmed in health care and more than 3 million deaths occur annually due to unsafe care. In low-to-middle income countries, as many as 4 in 100 people die from unsafe care. Above 50%…
World Lymphoma Awareness Day is observed annually on September 15 and serves as a dedicated occasion for increasing awareness about lymphoma, an increasingly prevalent type of cancer. This global initiative is hosted by the Lymphoma Coalition, a non-profit network organization…
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythaemia vera and post-essential thrombocythaemia), in adults with anaemia. Ojjaara is…
Atopic eczema is an allergic skin condition that not only affects the skin but also plays a central role in various other health issues. It impacts mental health and leads to the development of other diseases. The disease is incredibly…
The new partnerships bring its total contributions to JPY 24.2 billion (Approx. USD 167.5 million) across 29 long-term partnerships. Takeda’s workforce is an integral part of the annual decision-making process as over 24,500 purpose-led employees participated in the selection of…
With cancer patients top of mind, teams of Bristol Myers Squibb employees will celebrate a decade of Coast 2 Coast 4 Cancer (C2C4C) this year and cycle nearly 3,000 miles from Oregon to New Jersey with the goal of raising…